BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 23415314)

  • 1. Combining neurohormonal blockade with continuous-flow left ventricular assist device support for myocardial recovery: a single-arm prospective study.
    Patel SR; Saeed O; Murthy S; Bhatia V; Shin JJ; Wang D; Negassa A; Pullman J; Goldstein DJ; Maybaum S
    J Heart Lung Transplant; 2013 Mar; 32(3):305-12. PubMed ID: 23415314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ventricular reconditioning and pump explantation in patients supported by continuous-flow left ventricular assist devices.
    Frazier OH; Baldwin AC; Demirozu ZT; Segura AM; Hernandez R; Taegtmeyer H; Mallidi H; Cohn WE
    J Heart Lung Transplant; 2015 Jun; 34(6):766-72. PubMed ID: 25447571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties.
    Klotz S; Barbone A; Reiken S; Holmes JW; Naka Y; Oz MC; Marks AR; Burkhoff D
    J Am Coll Cardiol; 2005 Mar; 45(5):668-76. PubMed ID: 15734609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac fibrosis and cellular hypertrophy decrease the degree of reverse remodeling and improvement in cardiac function during left ventricular assist.
    Saito S; Matsumiya G; Sakaguchi T; Miyagawa S; Yamauchi T; Kuratani T; Sawa Y
    J Heart Lung Transplant; 2010 Jun; 29(6):672-9. PubMed ID: 20188595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective Multicenter Study of Myocardial Recovery Using Left Ventricular Assist Devices (RESTAGE-HF [Remission from Stage D Heart Failure]): Medium-Term and Primary End Point Results.
    Birks EJ; Drakos SG; Patel SR; Lowes BD; Selzman CH; Starling RC; Trivedi J; Slaughter MS; Alturi P; Goldstein D; Maybaum S; Um JY; Margulies KB; Stehlik J; Cunningham C; Farrar DJ; Rame JE
    Circulation; 2020 Nov; 142(21):2016-2028. PubMed ID: 33100036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular reverse remodeling with a continuous flow left ventricular assist device measured by left ventricular end-diastolic dimensions and severity of mitral regurgitation.
    Morgan JA; Brewer RJ; Nemeh HW; Murthy R; Williams CT; Lanfear DE; Tita C; Paone G
    ASAIO J; 2012; 58(6):574-7. PubMed ID: 23103696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous-flow left ventricular assist device therapy in patients with preoperative hepatic failure: are we pushing the limits too far?
    Weymann A; Patil NP; Sabashnikov A; Mohite PN; Garcia Saez D; Bireta C; Wahlers T; Karck M; Kallenbach K; Ruhparwar A; Fatullayev J; Amrani M; De Robertis F; Bahrami T; Popov AF; Simon AR
    Artif Organs; 2015 Apr; 39(4):336-42. PubMed ID: 25345547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy.
    Hetzer R; Müller JH; Weng YG; Loebe M; Wallukat G
    J Thorac Cardiovasc Surg; 2000 Nov; 120(5):843-53. PubMed ID: 11044309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices.
    Dandel M; Weng Y; Siniawski H; Potapov E; Lehmkuhl HB; Hetzer R
    Circulation; 2005 Aug; 112(9 Suppl):I37-45. PubMed ID: 16159848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanical unloading leads to echocardiographic, electrocardiographic, neurohormonal, and histologic recovery.
    Xydas S; Rosen RS; Ng C; Mercando M; Cohen J; DiTullio M; Magnano A; Marboe CC; Mancini DM; Naka Y; Oz MC; Maybaum S
    J Heart Lung Transplant; 2006 Jan; 25(1):7-15. PubMed ID: 16399524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanical unloading during left ventricular assist device support increases left ventricular collagen cross-linking and myocardial stiffness.
    Klotz S; Foronjy RF; Dickstein ML; Gu A; Garrelds IM; Danser AH; Oz MC; D'Armiento J; Burkhoff D
    Circulation; 2005 Jul; 112(3):364-74. PubMed ID: 15998679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group.
    Maybaum S; Mancini D; Xydas S; Starling RC; Aaronson K; Pagani FD; Miller LW; Margulies K; McRee S; Frazier OH; Torre-Amione G;
    Circulation; 2007 May; 115(19):2497-505. PubMed ID: 17485581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced myocardial blood flow during left ventricular assist device support: a possible cause of premature bypass graft closure.
    Xydas S; Rosen RS; Pinney S; Hickey KT; Wasserman H; Mancini DM; Naka Y; Oz MC; Bergmann SR; Maybaum S
    J Heart Lung Transplant; 2005 Nov; 24(11):1976-9. PubMed ID: 16297808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biventricular assist device-induced right ventricular reverse structural and functional remodeling.
    Klotz S; Naka Y; Oz MC; Burkhoff D
    J Heart Lung Transplant; 2005 Sep; 24(9):1195-201. PubMed ID: 16143233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma neurohormone levels correlate with left ventricular functional and morphological improvement in LVAD patients.
    Thompson LO; Skrabal CA; Loebe M; Lafuente JA; Roberts RR; Akgul A; Jones V; Bruckner BA; Thohan V; Noon GP; Youker KA
    J Surg Res; 2005 Jan; 123(1):25-32. PubMed ID: 15652947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular normalization of dystrophin in the failing left and right ventricle of patients treated with either pulsatile or continuous flow-type ventricular assist devices.
    Vatta M; Stetson SJ; Jimenez S; Entman ML; Noon GP; Bowles NE; Towbin JA; Torre-Amione G
    J Am Coll Cardiol; 2004 Mar; 43(5):811-7. PubMed ID: 14998622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular assist device weaning: hemodynamic response and relationship to stroke volume and rate reduction protocols.
    Slaughter MS; Sobieski MA; Koenig SC; Pappas PS; Tatooles AJ; Silver MA
    ASAIO J; 2006; 52(3):228-33. PubMed ID: 16760709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LVAD decommissioning for myocardial recovery: Long-term ventricular remodeling and adverse events.
    Gerhard EF; Wang L; Singh R; Schueler S; Genovese LD; Woods A; Tang D; Smith NR; Psotka MA; Tovey S; Desai SS; Jakovljevic DG; MacGowan GA; Shah P
    J Heart Lung Transplant; 2021 Dec; 40(12):1560-1570. PubMed ID: 34479776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Neurohormonal Blockade Drug Therapy on Outcomes and Left Ventricular Function and Structure After Left Ventricular Assist Device Implantation.
    Grupper A; Zhao YM; Sajgalik P; Joyce LD; Park SJ; Pereira NL; Stulak JM; Burnett JC; Edwards BS; Daly RC; Kushwaha SS; Schirger JA
    Am J Cardiol; 2016 Jun; 117(11):1765-70. PubMed ID: 27079215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.